Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol

Endocrine Journal

Volumn 48, Issue 1, 2001, Pages 11-18

  Inoue, Tamotsu ^a   Sugiyama, Toshihiro ^a,b   Matsubara, Tomoyo ^a   Kawai, Shinya ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Glucocorticoid; Osteoporosis; Vitamin D; Vitamin K

Indexed keywords

ALFACALCIDOL; BIOCHEMICAL MARKER; FARNOQUINONE; GLUCOCORTICOID; MENATETRENONE; OSTEOCALCIN; PREDNISOLONE;

ADOLESCENT; ARTICLE; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CHILD; CLINICAL ARTICLE; DECARBOXYLATION; DRUG EFFECT; FEMALE; HUMAN; INTESTINE ABSORPTION; LUMBAR SPINE; LYMPHOCYTE TRANSFORMATION; MALE; MINERALIZATION; OSTEOPOROSIS; PROTEIN PROCESSING;

EID: 0035079560     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.11     Document Type: Article

References (29)

1. Drug-induced disorders of vitamin D and mineral metabolism
2. Alendronate for the prevention and treatment of corticosteroid-induced osteoporosis
3. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
4. Alfacalcidol in prevention of glucocorticoid-induced osteoporosis
5. The roles of vitamins D and K in bone health and osteoporosis prevention
6. Vitamin K and metabolic bone disease
7. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
8. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
9. 2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine
10. Effects of menatetrenone on prednisolone-induced bone loss in rats
11. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis
12. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro
13. 3-induced mineralization in human periosteal osteoblasts
14. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss
15. Vitamin K plus vitamin D treatment of bone problems in a child with skeletal unloading
16. Menatetrenone plus alfacalcidol treatment for bone problems in eight children with skeletal unloading
17. 3 in the prevention of bone loss induced by leuprolide
18. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
19. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study
20. Vitamin D receptor genotypes and bone mineral density
21. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin
22. 2 in human osteosarcoma cell line MG-63
23. Inhibitory actions of glucocorticoids on skeleton growth: Is local insulin-like growth factor I to blame?
24. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients
25. 3 plus prednisone on serum osteocalcin in normal individuals
26. 3 receptor
27. 2 (menatetrenone) on bone resorption may be related to its side chain
28. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis
29. Effects of menatetrenone on the decrease in calcium balance induced by vitamin K-deficient diet and sodium loading in rats